» Articles » PMID: 9974392

Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation

Overview
Journal Science
Specialty Science
Date 1999 Feb 12
PMID 9974392
Citations 174
Authors
Affiliations
Soon will be listed here.
Abstract

Erythropoietin receptor (EPOR) is thought to be activated by ligand-induced homodimerization. However, structures of agonist and antagonist peptide complexes of EPOR, as well as an EPO-EPOR complex, have shown that the actual dimer configuration is critical for the biological response and signal efficiency. The crystal structure of the extracellular domain of EPOR in its unliganded form at 2.4 angstrom resolution has revealed a dimer in which the individual membrane-spanning and intracellular domains would be too far apart to permit phosphorylation by JAK2. This unliganded EPOR dimer is formed from self-association of the same key binding site residues that interact with EPO-mimetic peptide and EPO ligands. This model for a preformed dimer on the cell surface provides insights into the organization, activation, and plasticity of recognition of hematopoietic cell surface receptors.

Citing Articles

Magnetogenetics as a promising tool for controlling cellular signaling pathways.

Latypova A, Yaremenko A, Pechnikova N, Minin A, Zubarev I J Nanobiotechnology. 2024; 22(1):327.

PMID: 38858689 PMC: 11163773. DOI: 10.1186/s12951-024-02616-z.


NGF, EPO, and IGF-1 in the Male Reproductive System.

Metallinou C, Staneloudi C, Nikolettos K, Asimakopoulos B J Clin Med. 2024; 13(10).

PMID: 38792459 PMC: 11122040. DOI: 10.3390/jcm13102918.


The Oligomeric State of Vasorin in the Plasma Membrane Measured Non-Invasively by Quantitative Fluorescence Fluctuation Spectroscopy.

Liang J, Smith A Int J Mol Sci. 2024; 25(7).

PMID: 38612924 PMC: 11012933. DOI: 10.3390/ijms25074115.


Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.

Maji L, Sengupta S, Matada G, Teli G, Biswas G, Das P Mol Divers. 2024; 28(6):4467-4513.

PMID: 38236444 DOI: 10.1007/s11030-023-10794-5.


Programmable synthetic receptors: the next-generation of cell and gene therapies.

Teng F, Cui T, Zhou L, Gao Q, Zhou Q, Li W Signal Transduct Target Ther. 2024; 9(1):7.

PMID: 38167329 PMC: 10761793. DOI: 10.1038/s41392-023-01680-5.